|

Allogenic islet cells (human, U. Chicago) Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • University of Chicago2

Indications

  • Diabetes Mellitus, Type 12
  • Diabetes2

Chicago, Illinois2 trials

Islet Transplantation in Patients With "Brittle" Type I Diabetes

University of Chicago Medical Center

N/A
Islet Transplantation in Type 1 Diabetic Kidney Allograft

The University of Chicago

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.